Wednesday, March 05, 2025 | 07:48 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

IHH Healthcare eyes listing SRL Diagnostics, plans to market brand abroad

Company to infuse another Rs 20 billion to acquire more of the equity

SRL
Premium

SRL (Photo: twitter.com/srlcare)

Sohini Das Mumbai
SRL Diagnostics, an arm of Fortis Healthcare, is likely to be listed on the stock exchanges in 2019.

IHH Healthcare Bhd of Malaysia, which is in the process of taking over SRL, has plans to take the brand to markets abroad in the medium to long term, sources claimed.

Meanwhile, IHH would be infusing about Rs 20 billion to meet additional fund requirements of Fortis Group. It has already infused Rs 40 billion as part of an earlier deal. 


The additional fund infusion

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in